Latest News on ACHC

Financial News Based On Company


Advertisement
Advertisement

Acadia Healthcare Company, Inc. Data Breach

https://www.federmanlaw.com/blog/acadia-healthcare-company-inc-data-breach/
Federman & Sherwood is investigating a data breach involving Acadia Healthcare Company, Inc. that affected over 860,000 people. The breach, which occurred in March and July 2026, exposed personal information such as names, Social Security numbers, addresses, and medical details. Acadia Healthcare is offering complimentary credit monitoring and identity theft protection to affected individuals.

Investment advisers' clients hold 2.58 million shares in Acadia Healthcare (ACHC).

https://www.stocktitan.net/sec-filings/ACHC/schedule-13g-a-acadia-healthcare-company-inc-amended-passive-investme-a440efde89a5.html
Wellington Management Group LLP and two affiliated entities reported beneficial ownership of 2,582,918 common shares, representing 2.77% of Acadia Healthcare Company, Inc. (ACHC), as of September 30, 2026. The shares are held of record by Wellington investment advisory clients, who possess the rights to dividends and sale proceeds. This disclosure was made in an amended Schedule 13G/A filing with the SEC.

Acadia Healthcare Stock: 6 Straight Green Days, Up 31%

https://www.trefis.com/stock/achc/articles/624526/acadia-healthcare-stock-6-straight-green-days-up-31/2026-11-12
Acadia Healthcare (ACHC) stock has surged 31% over six consecutive trading days, adding $834 million to its market value, largely driven by company-specific factors rather than broader market trends. While the stock has seen significant gains, its revenue growth and operating margin are below the S&P 500 Health Care median, and it lacks positive trailing earnings, presenting a mixed fundamental picture for investors. The article suggests that while such a climb warrants attention, a diversified strategy like the Trefis High Quality Portfolio is recommended over depending solely on one company's continued performance.

RBC Capital maintains Acadia Healthcare Co at Outperform, raises price target to $41 from $31

https://www.tradingview.com/news/tradingview:683615ebf59a9:0-rbc-capital-maintains-acadia-healthcare-co-at-outperform-raises-price-target-to-41-from-31/
RBC Capital maintained its Outperform rating for Acadia Healthcare Co (ACHC) and increased its price target from $31 to $41, representing a 32.3% hike and implying a 17.8% upside from the recent closing price. Other recent analyst actions from Guggenheim, Cantor Fitzgerald, and Barclays show price targets ranging from $35 to $41.

Cantor Fitzgerald maintains Acadia Healthcare Co at Neutral, raises price target to $39 from $30

https://www.tradingview.com/news/tradingview:bc473acc58af4:0-cantor-fitzgerald-maintains-acadia-healthcare-co-at-neutral-raises-price-target-to-39-from-30/
Cantor Fitzgerald has reaffirmed its "Neutral" rating for Acadia Healthcare Co (ACHC) and increased its price target to $39 from $30, marking a 30.0% hike. This new price target suggests a potential upside of 12.1% from the stock's closing price of $34.79 on November 5. Investors can find more detailed analyst data and ratings for Acadia Healthcare Co on the Forecasts tab of TradingView.
Advertisement

5 revealing analyst questions from Acadia Healthcare’s Q3 2026 earnings call

https://www.tradingview.com/news/stockstory:87d761ac2094b:0-5-revealing-analyst-questions-from-acadia-healthcare-s-q3-2026-earnings-call/
Acadia Healthcare (ACHC) exceeded Q3 2026 revenue and profit expectations, driven by strong patient volumes and cost controls, leading to a positive market reaction and raised full-year guidance. Analysts probed management on recovery opportunities, capital expenditures, revenue growth stabilization, bad debt moderation, and the impact of new Medicaid work requirements. The company is focusing on new facility ramp-up, operational efficiency, and pending supplemental payment programs to sustain profitability.

Barclays maintains Acadia Healthcare Co at Equal-Weight, raises price target to $35 from $32

https://www.tradingview.com/news/tradingview:617bba4d48d4b:0-barclays-maintains-acadia-healthcare-co-at-equal-weight-raises-price-target-to-35-from-32/
Barclays has reiterated its "Equal-Weight" rating for Acadia Healthcare Co (ACHC) and increased its price target from $32 to $35. This new target implies an 8.5% upside from the stock's closing price of $32.25 on November 4. The article also notes that further data and analyst recommendations are available on TradingView.

Acadia Healthcare Q3 Revenue Rises 5.1% as Non-GAAP EPS Beats Estimate

https://www.tokenpost.com/news/business/49575
Acadia Healthcare (ACHC) reported a 5.1% year-over-year increase in third-quarter revenue, reaching $895.3 million. The company's non-GAAP earnings per share of $0.60 surpassed estimates by $0.14, and revenue also exceeded expectations. Additionally, Acadia Healthcare added 220 licensed beds during the quarter.

Acadia Healthcare Q3 Earnings Call Highlights

https://www.tradingview.com/news/marketbeat:f324843ca094b:0-acadia-healthcare-q3-earnings-call-highlights/
Acadia Healthcare (ACHC) exceeded expectations in Q3 2026, with revenue up 5.1% to $895 million and adjusted EBITDA at $176.4 million. The company raised its full-year 2026 financial guidance for the third consecutive quarter, forecasting revenue between $3.44 billion and $3.46 billion and adjusted EBITDA of $615 million to $625 million. Growth was primarily driven by acute facilities and new bed additions, with expectations for $60 million in incremental adjusted EBITDA in 2027 from facilities opened since 2023.

Acadia Healthcare Co Q3 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/11/62927558/acadia-healthcare-co-q3-2026-earnings-call-transcript
Acadia Healthcare Co reported strong Q3 2026 results, with revenue increasing 5.1% year-over-year to $895 million, driven by solid patient volume and revenue per patient day growth. The company successfully opened new facilities, adding 542 beds in 2026, and significantly reduced debt by $63 million while generating $47 million in free cash flow. Acadia raised its full-year guidance for revenue, adjusted EBITDA, and operating cash flow, expecting $60 million in incremental adjusted EBITDA in 2027 from recently opened facilities.
Advertisement

Acadia Healthcare stock hits 52-week high at $37.44 By Investing.com

https://ca.investing.com/news/stock-market-news/acadia-healthcare-stock-hits-52week-high-at-3744-93CH-4935407
Acadia Healthcare (ACHC) stock has reached a new 52-week high of $37.44, reflecting a significant 59.18% increase over the past year and a 127% year-to-date return. Despite its strong performance, InvestingPro Tips suggest the shares may be slightly overvalued, though analysts forecast a return to profitability in fiscal 2026 with expected earnings of $1.52 per share. Recent analyst ratings include a reiterated Neutral from Cantor Fitzgerald with a $30.00 target and an Outperform initiation from Raymond James with a $39.00 target.

Acadia Healthcare stock hits 52-week high at $37.44

https://www.investing.com/news/company-news/acadia-healthcare-stock-hits-52week-high-at-3744-93CH-5004804
Acadia Healthcare Company Inc. (ACHC) stock has reached a new 52-week high of $37.44, representing a 59.18% increase over the past year and a 127% year-to-date return. Despite this strong performance, InvestingPro's Fair Value analysis suggests the shares may be slightly overvalued. Analysts forecast the company to return to profitability in fiscal 2026 with estimated earnings of $1.52 per share.

Acadia Healthcare (NASDAQ:ACHC) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations

https://markets.financialcontent.com/stocks/article/stockstory-2026-11-4-acadia-healthcare-nasdaqachc-exceeds-q3-2026-expectations-full-year-outlook-slightly-exceeds-expectations
Acadia Healthcare (NASDAQ: ACHC) surpassed Q3 2026 revenue and adjusted EPS expectations, reporting a 5.1% year-on-year revenue increase to $895.3 million and an adjusted EPS of $0.60. The company also raised its full-year revenue, adjusted EPS, and EBITDA guidance, reflecting strong performance and positive momentum. CEO Debbie Osteen highlighted expansions and operational execution as key drivers for continued growth and value creation.

Acadia Healthcare Company Surges 10.9% Amid Sector-Wide Rally

https://news.alphastreet.com/acadia-healthcare-company-surges-10-9-amid-sector-wide-rally/
Acadia Healthcare Company, Inc. (ACHC) saw its stock surge by 10.9% to $32.84 on November 4, 2026, driven by a broad-based rally across the medical care facilities sector. This rally was attributed to sector momentum and potentially broader investor appetite for healthcare providers rather than company-specific news, with other peers like Universal Health Services and PACS also experiencing significant gains. Investors are advised to monitor whether this sector momentum is sustained and if any fundamental catalysts emerge to explain the coordinated move.

Acadia Healthcare earnings up next: Profitability in focus By Investing.com

https://in.investing.com/news/stock-market-news/acadia-healthcare-earnings-up-next-profitability-in-focus-93CH-5679928
Acadia Healthcare Company Inc. (ACHC) is set to report third-quarter earnings with investors focusing on the company's progress toward normalized profitability amidst concerns about professional liability claims and staffing. Analysts expect earnings of 46 cents per share on revenue of $877.8 million, showing sequential improvement but a year-over-year decline due to expansion costs. Wall Street maintains a "buy" rating with a mean price target of $33.79, implying a 14% upside.
Advertisement

Acadia Healthcare Company, Inc. (ACHC) Seasonal returns chart

https://uk.finance.yahoo.com/quote/ACHC/seasonality/
This article provides a brief overview of Acadia Healthcare Company, Inc. (ACHC), including its current stock price and upcoming Q3 2026 earnings call. It also features a historical seasonality chart showing average monthly price returns from 2016 to 2026. The information is presented by Yahoo Finance.

Acadia Healthcare (ACHC) to report earnings tomorrow: here is what to expect

https://www.tradingview.com/news/stockstory:49d5813f7094b:0-acadia-healthcare-achc-to-report-earnings-tomorrow-here-is-what-to-expect/
Acadia Healthcare (ACHC) is scheduled to report earnings tomorrow after market close. The market anticipates a 3.1% year-on-year revenue growth, a slowdown from the previous year, though analysts have largely maintained their estimates. Historically, Acadia Healthcare has missed Wall Street's revenue estimates multiple times in the past two years, contrasting with recent strong performances from peers like Tenet Healthcare and HCA Healthcare.

Acadia Healthcare (ACHC) to report earnings tomorrow: here is what to expect

https://markets.financialcontent.com/stocks/article/stockstory-2026-11-3-acadia-healthcare-achc-to-report-earnings-tomorrow-here-is-what-to-expect
Acadia Healthcare (ACHC) is scheduled to report earnings after market close this Wednesday. The company previously beat revenue expectations and met full-year guidance, with analysts reconfirming estimates for the upcoming quarter. While Acadia Healthcare has missed revenue estimates in the past, the hospital chains segment, including peers like Tenet Healthcare and HCA Healthcare, has shown positive sentiment recently.

Acadia Healthcare Company, Inc. (1ACHC.MI) Seasonal returns chart

https://uk.finance.yahoo.com/quote/1ACHC.MI/seasonality/
This article from Yahoo Finance provides a seasonal returns chart for Acadia Healthcare Company, Inc. (1ACHC.MI). It shows the average monthly price return for the company between 2025 and 2026, and also lists related tickers. The page also provides key financial data such as the current stock price and a reminder of the upcoming Q3 2026 earnings call.

Acadia Healthcare Company, Inc. (ACHC) Seasonal Returns Chart - Yahoo Finance

https://ca.finance.yahoo.com/quote/ACHC/seasonality/
The article displays the historical seasonality chart for Acadia Healthcare Company, Inc. (ACHC), showing average monthly price returns from 2016 to 2026. As of November 2, the stock was trading at $29.62, down 1.13% at market close.
Advertisement

Acadia Healthcare Company, Inc. (ACHC) Seasonal returns chart

https://au.finance.yahoo.com/quote/ACHC/seasonality/
The article provides a seasonal returns chart for Acadia Healthcare Company, Inc. (ACHC), showing the average monthly price return from 2016 to 2026. It includes current stock information, showing ACHC at $29.62, down 1.13% at market close on November 2nd. The page emphasizes historical seasonality data for the company.

Acadia Healthcare Company, Inc. Balance Sheet – TRADEGATE:7RA

https://www.tradingview.com/symbols/TRADEGATE-7RA/financials-balance-sheet/
Acadia Healthcare Company, Inc. (TRADEGATE:7RA) reported its Q2 2026 financial position, showing total assets of ‪4.86 billion EUR, an increase of 1.16% from Q1 2026. Total liabilities also rose by 0.46% to ‪2.94 billion EUR in the same period. The article provides a tabular overview of financial metrics including total assets, liabilities, equity, and debt from 2009 through 2025.

New Standard of Care

https://mcdmag.com/2026/10/new-standard-of-care/
CenterPointe Hospital in Columbia, Missouri, has introduced the first complete Wireless Environment of Care in an inpatient behavioral health facility, utilizing TAGCarts' wireless charging system. An independent study showed that this innovation significantly reduced nurses' workload, with no participant reporting increased workload or opposing permanent adoption. This system enhances safety and compliance by eliminating floor-level cords and is being implemented in other Acadia Healthcare facilities.

National HealthCare Drops 5.2% Amid Sector-Wide Selling

https://news.alphastreet.com/national-healthcare-drops-5-2-amid-sector-wide-selling/
National HealthCare Corporation's shares fell 5.2% on Tuesday, closing at $211.97, as a broad selloff impacted the healthcare facilities sector. The decline, which also affected peers like Universal Health Services and Acadia Healthcare, was driven by sector-wide pressure rather than company-specific news. Investors are now questioning whether this represents a temporary rotation or the start of sustained pressure on medical care facility operators.

Acadia Healthcare Company, Inc. Estimates – NASDAQ:ACHC

https://www.tradingview.com/symbols/NASDAQ-ACHC/financials-estimates/
This article provides an overview of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) financial estimates, including income statement, balance sheet, cash flow, and valuation metrics. It highlights the availability of reported financial data and analyst estimates, allowing users to compare actual results with average, high, and low estimates and visualize trends over time. The content is presented as a financial overview from TradingView, emphasizing that it is not investment advice.
Advertisement

Raymond James sets USD 39.00 target for Acadia Healthcare stock

https://www.ad-hoc-news.de/boerse/news/nebenwerte/raymond-james-sets-usd-39-00-target-for-acadia-healthcare-stock/70378387
Raymond James has initiated coverage on Acadia Healthcare (ACHC) with an Outperform rating and a $39.00 price target, representing a 24.09% upside from its October 20, 2026 Nasdaq price. The company is set to release its third-quarter 2026 results on November 4, 2026, followed by a conference call on November 5. Acadia Healthcare, which operates behavioral healthcare facilities, reported Q2 2026 revenue of $865.8 million and has a full-year 2026 revenue guidance of $3.40 billion to $3.45 billion.

What Acadia Healthcare Stock Momentum Means For Shareholders

https://simplywall.st/stocks/us/healthcare/nasdaq-achc/acadia-healthcare/news/what-acadia-healthcare-stock-momentum-means-for-shareholders
Acadia Healthcare Company's stock has gained attention due to its facility expansion, specialty treatment, and operational adjustments, including early AI adoption in billing. Despite recent stock momentum, the underlying investment thesis remains centered on behavioral health capacity expansion and operational improvements. Key risks include Medicaid reimbursement pressures, legal expenses, and underperforming facilities, while analysts project significant revenue and earnings growth by 2029.

What Acadia Healthcare Stock Momentum Means For Shareholders

https://simplywall.st/stocks/us/healthcare/nasdaq-achc/acadia-healthcare/news/what-acadia-healthcare-stock-momentum-means-for-shareholders/amp
Acadia Healthcare Company (ACHC) is gaining investor attention due to its facility expansion, specialty treatment focus, and operational improvements, including the early use of AI in billing. Despite risks like Medicaid reimbursement pressures and legal expenses, the stock is considered approximately 11% undervalued. The company's future growth hinges on successful facility ramp-up and AI-supported billing offsetting these challenges.

Acadia Healthcare Company (ACHC) Could Be 11% Undervalued On Its Growth Narrative

https://finance.yahoo.com/markets/stocks/articles/acadia-healthcare-company-achc-could-181356124.html
Acadia Healthcare Company (ACHC) has seen a recent share price climb, attributed more to sector sentiment and a rotation into healthcare stocks than new company-specific updates. Despite short-term gains, the stock has experienced significant declines over longer periods. Simply Wall St's analysis suggests ACHC could be 11% undervalued, with a fair value of $33.79, driven by accelerated facility development and expansion, though risks like Medicaid reimbursement changes and rising legal costs could impact this outlook.

Raymond James sets USD 39.00 target for Acadia Healthcare stock

https://www.ad-hoc-news.de/boerse/news/nebenwerte/raymond-james-sets-usd-39-00-target-for-acadia-healthcare-stock/70331524
Raymond James has initiated coverage on Acadia Healthcare (ACHC) with an Outperform rating and a $39.00 price target, implying a significant upside from its current Nasdaq price. This valuation comes as Acadia Healthcare reported strong second-quarter revenues, exceeding analyst expectations. The company is set to release its third-quarter results on November 4, 2026.
Advertisement

Why Is Acadia Healthcare (NASDAQ:ACHC) Up 9.81% in a Week, and Can the Rally Last?

https://kalkine.ca/news/general-news/why-is-acadia-healthcare-nasdaqachc-up-981-in-a-week-and-can-the-rally-last
Acadia Healthcare (NASDAQ:ACHC) experienced a 9.81% increase in its stock price over the past week, closing at USD 31.67 on October 14. This rally appears to be driven by sector momentum and rotation into healthcare stocks, rather than specific company news, as no relevant announcements were found. Investors are advised to watch for company filings, sector sentiment, and upcoming earnings to assess the sustainability of this upward trend.

Acadia Healthcare Company, Inc. (ACHC) Stock Forecasts

https://finance.yahoo.com/research/reports/ARGUS_4764_QuantitativeReport_1791936000000
Argus has raised its target price for Acadia Healthcare Company, Inc. (ACHC) to $32.00, citing the company's focus on acquiring and developing behavioral healthcare facilities. Acute inpatient psychiatric and specialty treatment facilities are the primary drivers of Acadia's revenue in the United States. The report suggests an upgrade for users to access more premium research and detailed insights.

Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

https://www.morningstar.com/news/pr-newswire/20261013ny71080/did-acadia-healthcare-company-inc-insiders-breach-their-fiduciary-duties-to-shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders of Acadia stock to contact them to discuss potential legal actions, including corporate governance reforms, return of funds to the company, or other relief. This investigation aims to enhance corporate accountability and shareholder value.

Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release

https://www.lelezard.com/en/news-acadia-healthcare-announces-date-for-third-quarter-2026-earnings-release-22399846.html
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) announced it will release its third-quarter 2026 financial results on Wednesday, November 4, 2026, after the market closes. The company will host a conference call for investors and analysts on Thursday, November 5, 2026, at 9:00 a.m. ET, with a live webcast available on its investor relations website. Acadia Healthcare is a major provider of behavioral healthcare services across the U.S., operating 279 facilities in 40 states and Puerto Rico.

Investigation launched into Acadia Healthcare's officers for possible breach of shareholder duties

https://pluang.com/en/news-feed/apakah-petinggi-acadia-healthcare-langgar-tugas-fidusia
Halper Sadeh LLC has launched an investigation into potential breaches of fiduciary duties by officers and directors of Acadia Healthcare Company (ACHC). Long-term shareholders are encouraged to contact the law firm to explore options for corporate governance reforms or financial relief. This action aims to improve company oversight and potentially compensate affected investors.
Advertisement

Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release

https://finance.yahoo.com/healthcare/articles/acadia-healthcare-announces-date-third-130000859.html
Acadia Healthcare Company, Inc. announced that its third-quarter 2026 earnings results will be released on Wednesday, November 4, 2026, after market close. The company will then host a conference call for investors and analysts on Thursday, November 5, 2026, at 9:00 a.m. ET to discuss the results. A live webcast will be available on their investor relations website, with an archived version accessible afterward.

USU00434AJ65 Bond Yield and Price — BONDSCOM:USU00434AJ65

https://www.tradingview.com/symbols/BONDSCOM-USU00434AJ65/
This page provides detailed information on the Acadia Healthcare Company, Inc. 7.375% 15-MAR-2033 bond, identified by ISIN USU00434AJ65. It covers key terms such as outstanding amount, face value, coupon rate, and maturity date, along with issuer details and credit rating information. The bond has an outstanding amount of $550 million USD and a coupon of 7.38% paid semi-annually, maturing on March 15, 2033.

An adviser reports 4.7M Acadia Healthcare (ACHC) shares owned by funds.

https://www.stocktitan.net/sec-filings/ACHC/schedule-13g-acadia-healthcare-company-inc-passive-investment-disclos-7b545cf491b5.html
Dimensional Fund Advisors LP reported a 5.0% beneficial ownership stake in Acadia Healthcare Company, Inc. (ACHC), totaling 4,698,457 shares as of September 30, 2026. The firm holds sole voting power over 4,594,468 shares and sole dispositive power over 4,698,457 shares, with no shared powers. Dimensional disclaims beneficial ownership of these securities, noting they are owned by various Funds and no single Fund holds more than 5% of the class.

Will Acadia Healthcare (ACHC) Beat Estimates Again in Its Next Earnings Report?

https://finance.yahoo.com/markets/stocks/articles/acadia-healthcare-achc-beat-estimates-151004428.html
Acadia Healthcare (ACHC) is projected to beat its upcoming earnings estimates, continuing a strong trend of outperforming expectations. The company's positive Zacks Earnings ESP of +4.84% combined with a Zacks Rank #2 (Buy) indicates a high probability of another earnings beat. This analysis suggests investors should consider ACHC due to its consistent earnings surprises and favorable analytical indicators.

Acadia Healthcare (ACHC): Buy, Sell, or Hold Post Q2 Earnings?

https://www.tradingview.com/news/stockstory:df69b6f08094b:0-acadia-healthcare-achc-buy-sell-or-hold-post-q2-earnings/
Acadia Healthcare (ACHC) shares have returned 13.5% over the last six months, slightly underperforming the S&P 500. However, analysts are wary due to weak sales volumes, declining EPS, and a decreasing return on invested capital (ROIC). The company's current valuation at 17.1x forward P/E suggests optimism is already priced in, leading to a recommendation to look for better investment opportunities elsewhere.
Advertisement

Cantor Fitzgerald reiterates Acadia Healthcare stock rating at Neutral

https://in.investing.com/news/stock-market-news/cantor-fitzgerald-reiterates-acadia-healthcare-stock-rating-at-neutral-93CH-5620406
Cantor Fitzgerald reiterated a Neutral rating on Acadia Healthcare (NASDAQ:ACHC) with a $30.00 price target. The firm believes that a management change led to an operational shift in job posting, which skews quarter-over-quarter data, but suggests staffing is stable. Analysts predict the company will be profitable this year with an EPS forecast of $1.52, despite operating with a significant debt burden.

How Higher Earnings Estimates Will Impact Acadia Healthcare Stock (ACHC)

https://simplywall.st/stocks/us/healthcare/nasdaq-achc/acadia-healthcare/news/how-higher-earnings-estimates-will-impact-acadia-healthcare
Acadia Healthcare (ACHC) has seen higher earnings estimates and a rating upgrade, reflecting improved profit outlook expectations. The company's stock has performed strongly year-to-date, with returns over 100%, leading to increased investor focus on its operating model and facility mix. While analysts are more confident in the path to profitability, the actual outcome depends on reimbursement stability, legal spending, and effective management of expansion and underperforming sites.

Acadia Healthcare (ACHC) Upgraded to Buy: Here's What You Should Know

https://finance.yahoo.com/markets/stocks/articles/acadia-healthcare-achc-upgraded-buy-150006456.html
Acadia Healthcare (ACHC) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates, which is a significant factor impacting stock prices. This upgrade reflects positivity about the company's earnings outlook, which could lead to increased buying pressure and a rise in its stock price. The Zacks Rank system, which correlates earnings estimate revisions with stock movements, indicates that ACHC is a strong candidate for market-beating returns.

Acadia Healthcare Company (ACHC) Rebounds Sharply, Is The Stock Still A Bargain?

https://simplywall.st/stocks/us/healthcare/nasdaq-achc/acadia-healthcare/news/acadia-healthcare-company-achc-rebounds-sharply-is-the-stock
Acadia Healthcare Company (ACHC) has seen a sharp rebound with a 96.36% year-to-date share price return, though its 1-year and 3-year returns are more modest or negative. Despite this, the stock is considered 17% undervalued by a popular narrative, with a fair value of $33.79 against its $28.06 close. However, significant start-up losses from facility expansion, potential execution risks, and rising malpractice expenses could challenge this undervalued assessment.

Acadia Healthcare Company (ACHC) Rebounds Sharply, Is The Stock Still A Bargain?

https://simplywall.st/stocks/us/healthcare/nasdaq-achc/acadia-healthcare/news/acadia-healthcare-company-achc-rebounds-sharply-is-the-stock/amp
Acadia Healthcare Company (ACHC) has seen a sharp rebound in its share price year-to-date, despite a softer 3-year performance. The company is considered 17% undervalued by some metrics, with a fair value pegged at $33.79 against its last close of $28.06. However, potential execution risks related to facility expansion and increased expenses could challenge this undervaluation narrative.
Advertisement

ACHC Q1 Deep Dive: Operational Changes and Payer Headwinds Shape Outlook

https://www.theglobeandmail.com/investing/markets/stocks/ACHC/pressreleases/1673191/achc-q1-deep-dive-operational-changes-and-payer-headwinds-shape-outlook/
Acadia Healthcare (ACHC) reported Q1 CY2026 revenue that exceeded analyst expectations, driven primarily by its acute inpatient psychiatric business. Despite the revenue beat, the company faced challenges in specialty facilities and elevated payer denials, leading to a negative market reaction. Management's outlook focuses on operational execution, mitigating payer risks, and leveraging new facilities to drive future growth and margin expansion.

Raymond James assumes Acadia Healthcare stock coverage with outperform rating

https://www.investing.com/news/analyst-ratings/raymond-james-assumes-acadia-healthcare-stock-coverage-with-outperform-rating-93CH-4920179
Raymond James has initiated coverage on Acadia Healthcare (NASDAQ:ACHC) with an Outperform rating and a $39.00 price target, citing strong demand for behavioral health services and effective management. The firm projects EBITDA growth of over 5% from 2025 through 2028, with the stock currently appearing undervalued.

Acadia Healthcare Company, Inc. (ACHC) stock price, news, quote and history

https://au.finance.yahoo.com/quote/ACHC/
This article provides detailed financial information for Acadia Healthcare Company, Inc. (ACHC), including its current stock price, historical performance, key financial metrics, and analyst ratings. It highlights the company's business overview as a behavioral healthcare services provider and compares its stock performance against the S&P 500. The content includes earnings trends, valuation measures, and balance sheet data.

ACHC6023634 Bond Profile: Coupon and Redemption

https://www.tradingview.com/symbols/FINRA-ACHC6023634/profile/
This article provides a detailed profile of the ACHC6023634 bond issued by Acadia Healthcare Company, Inc. It outlines key facts about the bond, including its issuer type, issue and maturity dates, face value, and minimum denomination. The profile also covers the bond's classification, credit risk assessment, and details regarding its semi-annual fixed-rate coupon payments, including a schedule of upcoming payouts.

A court preliminarily approved a settlement involving Acadia Healthcare (ACHC). Final approval is pending.

https://www.stocktitan.net/sec-filings/ACHC/8-k-acadia-healthcare-company-inc-reports-material-event-761df2255fd0.html
A U.S. District Court has preliminarily approved a proposed settlement in shareholder derivative actions against Acadia Healthcare Company, Inc. (ACHC), involving a $12 million payment to Acadia from its insurers and the implementation of significant corporate governance reforms. Final court approval is still pending for both the settlement and a requested $4.75 million in attorneys' fees and expenses. This settlement aims to resolve claims alleging fiduciary duty breaches, corporate asset waste, and unjust enrichment by certain individual defendants.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement